Abtrace, a London UK-based healthtech startup, raised £2.1 Million in seed funding led by Faber with participation from Ganexa Capital.
The company intends to use the funds to roll the technology out to new GP practices across the UK and expand its engineering and data, science teams.
Company: Abtrace Ltd
Round: Seed Round
Funding Month: August 2021
Lead Investors: Faber
Additional Investors: Ganexa Capital
Company Website: https://www.abtrace.co/
Software Category: AI-based solutions
About the Company: Led by co-founder and CEO Dr. Umar Naeem Ahmad, Abtrace uses machine learning to provide advanced digital solutions that allow healthcare professionals to react and manage the patient’s current diseases and to recognize the first clinical signs of new conditions. The company has built an AI tool that can plug into the Electronic Health Record (EHR) database and identify which tests or treatments a patient with a long-term health condition needs or might benefit from. The software allows GPs and healthcare assistants (HCAs) to make more informed decisions, automate key elements of disease monitoring, and ensure patients receive consistent, effective care.